Maduramicin

A polyether ionophore antibiotic.

Phase of research

Potential treatment - pre-clinical evidence

How it helps

Antiviral

Drug status

Experimental

2
Supporting references
0
Contradictory references
0
AI-suggested references
0
Clinical trials

General information

Maduramicin is an o-glycosyl antiprotozoal compound used in veterinary medicine (DrugBank).

Maduramicin (ammonium) on PubChem
Maduramicin on Wikipedia


Synonyms

Maduramicin ammonium; Maduramycin

 

Structure image - Maduramicin

C[C@H]1C[C@H]([C@@](O[C@@H]1[C@H]2C[C@@H]([C@@H](O2)[C@@]3(CC[C@@H](O3)[C@@]4(CC[C@@]5(O4)C[C@@H]([C@H]([C@H](O5)[C@@H](C)[C@H]6[C@@H]([C@H]([C@@H]([C@](O6)(CC(=O)O)O)C)OC)OC)C)O)C)C)O[C@@H]7C[C@@H]([C@H]([C@@H](O7)C)OC)OC)(C)O)C


Supporting references

Link Tested on Impact factor Notes Publication date
Ionophore antibiotic X-206 is a potent inhibitor of SARS-CoV-2 infection in vitro
Small molecule In vitro
Vero E6 cells; Vero E6-hTMPRSS2 cells; Calu-3 cells 4.10

Inhibited SARS-CoV-2 in cell culture with high selectivity (the ratio between IC50 and EC50).

Nov/25/2020
Identification of existing pharmaceuticals and herbal medicines as inhibitors of SARS-CoV-2 infection
3CLpro PapainLpro Enzyme assay Animal model In vitro In silico
in silico; in vitro enzyme assay; Vero E6 cells; golden Syrian hamsters; SARS-CoV-2 clinical isolate hCoV-19/Taiwan/4/2020 9.41

Inhibited SARS-CoV-2 infection in Vero E6 cells (selectivity index of ca. 4.8 - although described as "no selectivity" by the authors in the text).

Jan/15/2021